Spatial transcriptome and single-cell sequencing reveal the role of nucleotide metabolism in breast cancer progression and tumor microenvironment

In conclusion, we developed a nucleotide metabolism-derived prognostic signature for BC, with DCTPP1 highlighted as a promising biomarker and therapeutic target. These findings provide a valuable framework for early clinical intervention and show promising potential for predicting responses to immunotherapy in BC patients.